Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous close | 16.480 |
| Open | 16.480 |
| Bid | 16.300 x N/A |
| Ask | 16.320 x N/A |
| Day's range | 15.980 - 16.580 |
| 52-week range | 9.410 - 18.760 |
| Volume | |
| Avg. volume | 4,716,286 |
| Market cap | 96.78B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 29.14 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.21 (1.30%) |
| Ex-dividend date | 19 Jun 2024 |
| 1y target est | N/A |
- GlobeNewswire
SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China
JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.
© 2024 Yahoo. All rights reserved.